← Leaderboards
Khashayar Farsad
Oregon Health & Science University
$285,821
Attributed
$391,653
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $211.7K · FY2021–22$250K$187.5K$125K$62.5K$0
'21
'22
Funding mix
By agency
NIH$391,653 · 1
By mechanism
R21$391,653 · 1
Top collaborators
- Wassana Yantasee1 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Alison Y Ting$2,774,032
- Martina Ralle$3,550,634
- Paul G Tratnyek$1,485,330
Others in their field
Other Emerging Leaders on “Antineoplastic Agents”
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$29,626,259
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,126,294
- Jeffrey H. Price · Vala Sciences, Inc.$5,562,326
Research focus
Antineoplastic AgentsApoptosisArteriesAutophagocytosisBaseBlood GlucoseCancer CellCancer TherapyCatalystCathetersCell DeathCell ProliferationCessation Of LifeChelating AgentsChemoembolizationChemotherapyClinical TranslationConsumptionCyanine Dye 5Cytotoxic ChemotherapyCytotoxinDiagnosisDrug KineticsAnti-Cancer